Table of Content
"1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS & EXCLUSIONS 44
1.3 MARKET SCOPE 45
1.3.1 MARKETS COVERED 45
1.3.2 YEARS CONSIDERED FOR THE STUDY 45
1.4 CURRENCY 46
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 46
1.5 LIMITATIONS 46
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH DATA 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 50
FIGURE 2 PRIMARY SOURCES 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Key industry insights 53
2.1.2.3 Breakdown of primary interviews: By company type, designation,
and region 53
2.2 MARKET SIZE ESTIMATION 54
FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 54
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF BLOOD COLLECTION PRODUCTS AND METHODS 55
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 56
FIGURE 6 TOP-DOWN APPROACH 57
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 7 DATA TRIANGULATION METHODOLOGY 58
2.4 MARKET SHARE ANALYSIS 58
2.5 ASSUMPTIONS FOR THE STUDY 59
2.6 LIMITATIONS 59
2.6.1 METHODOLOGY-RELATED LIMITATIONS 59
2.7 RISK ASSESSMENT 60
TABLE 2 RISK ASSESSMENT: BLOOD COLLECTION DEVICES MARKET 60
2.8 COVID-19 HEALTH ASSESSMENT 60
2.9 COVID-19 ECONOMIC ASSESSMENT 60
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO 61
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 61
3 EXECUTIVE SUMMARY 63
FIGURE 10 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 63
FIGURE 11 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021 VS. 2026 (USD BILLION) 64
FIGURE 12 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 64
FIGURE 13 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 65
FIGURE 14 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021 VS. 2026 (USD BILLION) 66
4 PREMIUM INSIGHTS 67
4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW 67
FIGURE 15 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET GROWTH 67
4.2 BLOOD COLLECTION DEVICES MARKET BY BLOOD COLLECTION TUBES, BY TYPE,
2021 VS. 2026 (USD MILLION) 68
FIGURE 16 PLASMA WHOLE /BLOOD TUBES SEGMENT TO REGISTER THE HIGHEST CAGR 68
4.3 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD AND COUNTRY (2020) 68
FIGURE 17 MANUAL BLOOD COLLECTION TO ACCOUNT FOR THE LARGEST SHARE OF
THE NORTH AMERICAN MARKET 68
4.4 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2021–2026 69
FIGURE 18 HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES SEGMENT TO WITNESS THE HIGHEST GROWTH 69
4.5 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 69
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE BLOOD COLLECTION DEVICES MARKET 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 20 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 MARKET DRIVERS 71
5.2.1.1 Rising prevalence of infectious diseases with the emergence of newer pathogens and chronic & lifestyle diseases 71
5.2.1.2 Increasing number of hospitals and surgical centers 72
5.2.1.3 Rising number of accidents and trauma cases 72
5.2.1.4 Growing emergence of liquid biopsy tests 72
5.2.1.5 Rising demand and awareness for blood donations and blood components 73
TABLE 3 GLOBAL CANCER PREVALENCE, 2018 VS. 2025 73
5.2.2 RESTRAINTS 75
5.2.2.1 Rising costs of automated blood collection devices 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Increasing demand for apheresis 75
5.2.3.2 Growing number of emerging economies offer lucrative opportunities 75
5.2.3.3 Rising advancements in blood collection—microsampling and dried blood sampling 76
5.2.4 CHALLENGES 76
5.2.4.1 Increasing complexities of storage and shipping 76
5.2.4.2 Increasing incidences in the lack of skilled professionals 77
5.3 IMPACT OF COVID-19 ON THE BLOOD COLLECTION DEVICES MARKET 77
5.4 RANGES/SCENARIOS 78
5.4.1 BLOOD COLLECTION DEVICES MARKET 78
FIGURE 21 PESSIMISTIC SCENARIO 78
FIGURE 22 OPTIMISTIC SCENARIO 79
FIGURE 23 REALISTIC SCENARIO 79
5.5 REGULATORY ANALYSIS 80
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 80
5.5.1 NORTH AMERICA 81
5.5.1.1 US 81
5.5.1.2 Canada 81
5.5.2 EUROPE 81
5.5.3 ASIA PACIFIC 81
5.5.3.1 Japan 81
5.5.3.2 India 81
5.5.4 LATIN AMERICA 82
5.5.4.1 Brazil 82
5.5.5 MIDDLE EAST 82
5.6 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 5 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.6.1 THREAT OF NEW ENTRANTS 83
5.6.2 THREAT OF SUBSTITUTES 83
5.6.3 BARGAINING POWER OF BUYERS 83
5.6.4 BARGAINING POWER OF SUPPLIERS 83
5.6.5 DEGREE OF COMPETITION 83
5.7 TECHNOLOGY ANALYSIS 84
5.8 VALUE CHAIN ANALYSIS 85
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 85
5.9 SUPPLY CHAIN ANALYSIS 86
FIGURE 25 BLOOD COLLECTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS 87
5.10 ECOSYSTEM ANALYSIS 87
FIGURE 26 BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS 88
5.10.1 ROLE IN THE ECOSYSTEM 88
FIGURE 27 KEY PLAYERS IN THE BLOOD COLLECTION DEVICES MARKET 89
5.11 PATENT ANALYSIS 90
5.11.1 PATENT GRANTED TRENDS FOR BLOOD COLLECTION 90
FIGURE 28 PATENT GRANTED TRENDS OF BLOOD COLLECTION TUBES,
JANUARY 2011–JULY 2021 90
FIGURE 29 PATENT GRANTED TRENDS OF BLOOD COLLECTION SYSTEMS/MONITORS, JANUARY 2011– DECEMBER 2021 91
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 91
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR BLOOD COLLECTION TUBES PATENTS, JANUARY 2011—NOVEMBER 2021 92
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BLOOD COLLECTION SYSTEMS/MONITORS PATENTS,
JANUARY 2011— DECEMBER 2021 93
5.12 TRADE ANALYSIS 94
TABLE 6 IMPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 94
TABLE 7 EXPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD MILLION) 94
5.13 PRICING ANALYSIS 95
TABLE 8 PRICE RANGE FOR BLOOD COLLECTION DEVICES, BY COUNTRY 95
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 97
FIGURE 32 REVENUE SHIFT FOR THE BLOOD COLLECTION DEVICES MARKET 97
6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
TABLE 9 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 99
TABLE 10 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 99
6.2 BLOOD COLLECTION TUBES 100
6.2.1 IMPACT OF COVID-19 ON THE BLOOD COLLECTION TUBES MARKET 100
6.2.2 BLOOD COLLECTION TUBES MARKET, BY TYPE 100
TABLE 11 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 100
TABLE 12 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 101
TABLE 13 BLOOD COLLECTION TUBES MARKET, BY REGION,
2017–2020 (USD MILLION) 101
TABLE 14 BLOOD COLLECTION TUBES MARKET, BY REGION,
2021–2026 (USD MILLION) 101
6.2.2.1 Plasma/whole-blood tubes 102
TABLE 15 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN THE MARKET 102
TABLE 16 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 103
TABLE 17 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 103
TABLE 18 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION,
2017–2020 (USD MILLION) 103
TABLE 19 PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY REGION,
2021–2026 (USD MILLION) 104
6.2.2.1.1 EDTA tubes 104
6.2.2.1.1.1 EDTA tubes to hold the largest share of the plasma/whole blood collection tubes segment 104
TABLE 20 EDTA TUBES AVAILABLE IN THE MARKET 104
TABLE 21 EDTA TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 105
TABLE 22 EDTA TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 105
6.2.2.1.2 Heparin tubes 105
6.2.2.1.2.1 Heparin tubes to eliminate the need to wait for clots to form 105
TABLE 23 HEPARIN TUBES AVAILABLE IN THE MARKET 106
TABLE 24 HEPARIN TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 106
TABLE 25 HEPARIN TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 106
6.2.2.1.3 Coagulation tubes 107
6.2.2.1.3.1 Coagulation tubes to show high demand for specific tubes 107
TABLE 26 COAGULATION TUBES AVAILABLE IN THE MARKET 107
TABLE 27 COAGULATION TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 107
TABLE 28 COAGULATION TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 108
6.2.2.1.4 Glucose tubes 108
6.2.2.1.4.1 Increasing incidence of diabetes to drive the growth of the glucose tubes market 108
TABLE 29 GLUCOSE TUBES AVAILABLE IN THE MARKET 108
TABLE 30 GLUCOSE TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 109
TABLE 31 GLUCOSE TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 109
6.2.2.1.5 ESR tubes 109
6.2.2.1.5.1 Increasing prevalence of prominent diseases to support market growth 109
TABLE 32 ESR TUBES AVAILABLE IN THE MARKET 110
TABLE 33 ESR TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 110
TABLE 34 ESR TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
6.2.2.2 Serum tubes 111
6.2.2.2.1 Accuracy and stability are important advantages of using serum tubes 111
TABLE 35 SERUM TUBES AVAILABLE IN THE MARKET 111
TABLE 36 SERUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 112
TABLE 37 SERUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 112
6.2.3 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE 112
6.2.3.1 Impact of COVID-19 on the blood collection tubes market, by system type 112
TABLE 38 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 113
TABLE 39 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 113
6.2.3.2 Vacuum tubes 113
6.2.3.2.1 Advantages of vacuum tubes to account for the larger market share 113
TABLE 40 VACUUM TUBES AVAILABLE IN THE MARKET 113
TABLE 41 VACUUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 114
TABLE 42 VACUUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 114
6.2.3.3 Non-vacuum tubes 114
6.2.3.3.1 Cost constraints to drive consumer preference towards non-vacuum tubes 114
TABLE 43 NON-VACUUM TUBES AVAILABLE IN THE MARKET 115
TABLE 44 NON-VACUUM TUBES MARKET, BY REGION, 2017–2020 (USD MILLION) 115
TABLE 45 NON-VACUUM TUBES MARKET, BY REGION, 2021–2026 (USD MILLION) 116
6.3 NEEDLES & SYRINGES 116
6.3.1 INCREASING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET GROWTH 116
TABLE 46 NEEDLES & SYRINGES AVAILABLE IN THE MARKET 116
TABLE 47 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION,
2017–2020 (USD MILLION) 117
TABLE 48 BLOOD COLLECTION NEEDLES & SYRINGES MARKET, BY REGION,
2021–2026 (USD MILLION) 117
6.4 BLOOD BAGS 118
6.4.1 INCREASE IN BLOOD DONATIONS TO SUSTAIN PURCHASE AND USE OF BLOOD BAGS 118
TABLE 49 BLOOD BAGS AVAILABLE IN THE MARKET 118
6.4.2 IMPACT OF COVID-19 ON THE BLOOD BAGS MARKET 119
6.4.2.1 Standard blood bags 119
6.4.2.2 Inline systems 120
6.4.2.3 Filters 120
TABLE 50 BLOOD BAGS MARKET, BY TYPE, 2017–2020 (USD MILLION) 120
TABLE 51 BLOOD BAGS MARKET, BY TYPE, 2021–2026 (USD MILLION) 120
TABLE 52 BLOOD COLLECTION BAGS MARKET, BY REGION, 2017–2020 (USD MILLION) 121
TABLE 53 BLOOD COLLECTION BAGS MARKET, BY REGION, 2021–2026 (USD MILLION) 121
6.5 BLOOD COLLECTION SYSTEMS/MONITORS 121
6.5.1 RISING PREVALENCE OF BLOOD DISORDERS AND DEMAND FOR BLOOD TO ENSURE THE USE OF COLLECTION SYSTEMS 121
TABLE 54 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN THE MARKET 122
6.5.2 IMPACT OF COVID-19 ON BLOOD COLLECTION SYSTEMS/MONITORS MARKET 123
TABLE 55 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION,
2017–2020 (USD MILLION) 123
TABLE 56 BLOOD COLLECTION SYSTEMS/MONITORS MARKET, BY REGION,
2021–2026 (USD MILLION) 123
6.6 LANCETS 124
6.6.1 RISING GOVERNMENT SUPPORT FOR LANCET TO INCREASE THEIR ADOPTION 124
TABLE 57 LANCETS AVAILABLE IN THE MARKET 124
TABLE 58 BLOOD COLLECTION LANCETS MARKET, BY REGION,
2017–2020 (USD MILLION) 125
TABLE 59 BLOOD COLLECTION LANCETS MARKET, BY REGION,
2021–2026 (USD MILLION) 125
7 BLOOD COLLECTION DEVICES MARKET, BY METHOD 126
7.1 INTRODUCTION 127
TABLE 60 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 127
TABLE 61 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 127
7.2 MANUAL BLOOD COLLECTION 127
7.2.1 MANUAL BLOOD COLLECTION TO HOLD THE LARGEST MARKET SHARE 127
7.2.2 IMPACT OF COVID-19 ON THE MANUAL BLOOD COLLECTION DEVICES MARKET 128
TABLE 62 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 128
TABLE 63 MANUAL BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 129
7.3 AUTOMATED BLOOD COLLECTION 129
7.3.1 HIGHER SAFETY AND EFFICIENCY TO DRIVE DEMAND FOR AUTOMATED COLLECTION 129
7.3.2 MARKET TRENDS 129
7.3.3 IMPACT OF COVID-19 ON THE AUTOMATED BLOOD COLLECTION DEVICES MARKET 130
TABLE 64 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 130
TABLE 65 AUTOMATED BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 131
8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION 132
8.1 INTRODUCTION 133
TABLE 66 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 133
TABLE 67 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 133
8.2 DIAGNOSTICS 133
8.2.1 RISING DISEASE INCIDENCE AND ADOPTION OF POINT-OF-CARE TESTING TO DRIVE MARKET GROWTH 133
8.2.2 IMPACT OF COVID-19 ON THE DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET 135
TABLE 68 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 135
TABLE 69 DIAGNOSTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 135
8.3 THERAPEUTICS 136
8.3.1 NORTH AMERICA TO DOMINATE THE THERAPEUTIC BLOOD COLLECTION DEVICES MARKET 136
8.3.2 IMPACT OF COVID-19 ON THE THERAPEUTIC BLOOD COLLECTION DEVICES MARKET 136
TABLE 70 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 136
TABLE 71 THERAPEUTIC BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 137
9 BLOOD COLLECTION DEVICES MARKET, BY END USER 138
9.1 INTRODUCTION 139
TABLE 72 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 139
TABLE 73 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 139
9.2 HOSPITALS, ASC, & NURSING HOMES 140
9.2.1 INCREASING DISEASE AND TRAUMA INCIDENCE TO DRIVE MARKET GROWTH 140
TABLE 74 NUMBER OF SURGICAL PROCEDURES, 2015 VS. 2020 (MILLION) 140
TABLE 75 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION,
2017–2020 (USD MILLION) 141
TABLE 76 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, & NURSING HOMES, BY REGION,
2021–2026 (USD MILLION) 141
9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES 142
9.3.1 MARKET GROWTH TO WITNESS RISING DISEASE INCIDENCE AND INCREASING TESTING VOLUMES 142
TABLE 77 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2017–2020 (USD MILLION) 142
TABLE 78 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 143
9.4 BLOOD BANKS 143
9.4.1 RISE IN BLOOD DONATION VOLUMES TO DRIVE THE MARKET FOR BLOOD BANKS 143
TABLE 79 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2017–2020 (USD MILLION) 144
TABLE 80 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2021–2026 (USD MILLION) 144
9.5 OTHER END USERS 145
TABLE 81 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2017–2020 (USD MILLION) 145
TABLE 82 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2026 (USD MILLION) 145
10 BLOOD COLLECTION DEVICES MARKET, BY REGION 146
10.1 INTRODUCTION 147
TABLE 83 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2017–2020 (USD MILLION) 147
TABLE 84 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 147
10.2 NORTH AMERICA 148
FIGURE 33 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 149
TABLE 85 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 149
TABLE 86 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 150
TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 150
TABLE 88 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2021–2026 (USD MILLION) 150
TABLE 89 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 151
TABLE 90 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 91 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET,
BY TYPE, 2017–2020 (USD MILLION) 151
TABLE 92 NORTH AMERICA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 93 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2017–2020 (USD MILLION) 152
TABLE 94 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2021–2026 (USD MILLION) 152
TABLE 95 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2017–2020 (USD MILLION) 153
TABLE 96 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2021–2026 (USD MILLION) 153
TABLE 97 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 153
TABLE 98 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION) 154
TABLE 99 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2017–2020 (USD MILLION) 154
TABLE 100 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2021–2026 (USD MILLION) 154
10.2.1 US 155
10.2.1.1 US to be the largest market for blood collection devices both globally and in North America 155
TABLE 101 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025 156
TABLE 102 US: KEY MACROINDICATORS 157
10.2.1.2 Impact of COVID-19 on the market in the US 157
TABLE 103 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 157
TABLE 104 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 158
TABLE 105 US: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 158
TABLE 106 US: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 158
TABLE 107 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 159
TABLE 108 US: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 109 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 159
TABLE 110 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 160
TABLE 111 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 160
TABLE 112 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 160
TABLE 113 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 160
TABLE 114 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 161
TABLE 115 US: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 161
TABLE 116 US: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 161
10.2.2 CANADA 162
10.2.2.1 Growing volume of surgical procedures and the rising burden of cancer to support market growth 162
TABLE 117 SURGICAL PROCEDURES PERFORMED IN CANADA, 2019 162
TABLE 118 CANADA: KEY MACROINDICATORS 163
10.2.2.2 Impact of COVID-19 on the market in Canada 163
TABLE 119 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 163
TABLE 120 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 164
TABLE 121 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 164
TABLE 122 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 164
TABLE 123 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 165
TABLE 124 CANADA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 165
TABLE 125 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 165
TABLE 126 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 166
TABLE 127 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 166
TABLE 128 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 166
TABLE 129 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 167
TABLE 130 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 167
TABLE 131 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 167
TABLE 132 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 168
10.3 EUROPE 168
TABLE 133 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 169
TABLE 134 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 169
TABLE 135 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 170
TABLE 136 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 170
TABLE 137 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 170
TABLE 138 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 171
TABLE 139 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 171
TABLE 140 EUROPE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 171
TABLE 141 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 172
TABLE 142 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 172
TABLE 143 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 172
TABLE 144 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 173
TABLE 145 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 173
TABLE 146 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 173
TABLE 147 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 174
TABLE 148 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 174
10.3.1 GERMANY 174
10.3.1.1 Germany to hold the largest share of the market in Europe 174
TABLE 149 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2019 175
TABLE 150 GERMANY: KEY MACROINDICATORS 175
10.3.1.2 Impact of COVID-19 on the market in Germany 176
TABLE 151 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 176
TABLE 152 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 176
TABLE 153 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 177
TABLE 154 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 177
TABLE 155 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 177
TABLE 156 GERMANY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 178
TABLE 157 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 178
TABLE 158 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 178
TABLE 159 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 179
TABLE 160 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 179
TABLE 161 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 179
TABLE 162 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 180
TABLE 163 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 180
TABLE 164 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 180
10.3.2 FRANCE 181
10.3.2.1 Favorable initiatives and the development of diagnostic tests to showcase growth trajectory in France 181
TABLE 165 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2019 181
TABLE 166 FRANCE: KEY INDICATORS 182
10.3.2.2 Impact of COVID-19 on the market in France 182
TABLE 167 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 182
TABLE 168 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 183
TABLE 169 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 183
TABLE 170 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 171 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 184
TABLE 172 FRANCE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 173 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 184
TABLE 174 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 185
TABLE 175 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 185
TABLE 176 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 185
TABLE 177 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 186
TABLE 178 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 186
TABLE 179 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 186
TABLE 180 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 187
10.3.3 UK 187
10.3.3.1 Government support to prevent transmission of HIV, chronic diseases, and other infections to drive market growth 187
TABLE 181 SURGICAL PROCEDURES PERFORMED IN THE UK, 2019 188
TABLE 182 UK: KEY MACROINDICATORS 188
10.3.3.2 Impact of COVID-19 on the market in the UK 188
TABLE 183 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 189
TABLE 184 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 189
TABLE 185 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 189
TABLE 186 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 190
TABLE 187 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 190
TABLE 188 UK: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 190
TABLE 189 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 191
TABLE 190 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 191
TABLE 191 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 191
TABLE 192 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 191
TABLE 193 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 192
TABLE 194 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 192
TABLE 195 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 192
TABLE 196 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 193
10.3.4 ITALY 193
10.3.4.1 Low healthcare expenditure and slow growth in the healthcare sector to affect the market growth 193
TABLE 197 DIFFERENT SURGICAL PROCEDURES PERFORMED IN ITALY IN 2019 193
TABLE 198 ITALY: KEY INDICATORS 194
10.3.4.2 Impact of COVID-19 on the market in Italy 194
TABLE 199 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 194
TABLE 200 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 194
TABLE 201 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 195
TABLE 202 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 195
TABLE 203 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 195
TABLE 204 ITALY: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 205 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 196
TABLE 206 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 196
TABLE 207 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 197
TABLE 208 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 197
TABLE 209 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 197
TABLE 210 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 197
TABLE 211 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 198
TABLE 212 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 198
10.3.5 SPAIN 198
10.3.5.1 Increasing adoption of NAT technology to support market growth 198
TABLE 213 DIFFERENT SURGICAL PROCEDURES PERFORMED IN SPAIN IN 2019 199
TABLE 214 SPAIN: KEY INDICATORS 199
10.3.5.2 Impact of COVID-19 on the market in Spain 199
TABLE 215 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 200
TABLE 216 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 200
TABLE 217 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 200
TABLE 218 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 201
TABLE 219 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 201
TABLE 220 SPAIN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 201
TABLE 221 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 202
TABLE 222 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 202
TABLE 223 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 202
TABLE 224 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 202
TABLE 225 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 203
TABLE 226 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 203
TABLE 227 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 203
TABLE 228 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 204
10.3.6 REST OF EUROPE 204
TABLE 229 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP) 204
TABLE 230 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050 205
TABLE 231 SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2019 205
TABLE 232 SURGICAL PROCEDURES PERFORMED IN BELGIUM, 2019 205
TABLE 233 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 206
TABLE 234 ROE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 206
TABLE 235 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 206
TABLE 236 ROE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 207
TABLE 237 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 207
TABLE 238 ROE: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 207
TABLE 239 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 208
TABLE 240 ROE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 208
TABLE 241 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 208
TABLE 242 ROE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 208
TABLE 243 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 209
TABLE 244 ROE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 209
TABLE 245 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 209
TABLE 246 ROE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 210"
"10.4 ASIA PACIFIC 210
FIGURE 34 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 211
TABLE 247 APAC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 211
TABLE 248 APAC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 212
TABLE 249 APAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 212
TABLE 250 APAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 212
TABLE 251 APAC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 213
TABLE 252 APAC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 213
TABLE 253 APAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 213
TABLE 254 APAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 214
TABLE 255 APAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 214
TABLE 256 APAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 214
TABLE 257 APAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 215
TABLE 258 APAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 215
TABLE 259 APAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 215
TABLE 260 APAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 215
TABLE 261 APAC: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 216
TABLE 262 APAC: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 216
10.4.1 CHINA 216
10.4.1.1 China to dominate the market in the Asia Pacific region 216
TABLE 263 CHINA: KEY INDICATORS 217
10.4.1.2 Impact of COVID-19 on the market in China 217
TABLE 264 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 217
TABLE 265 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 218
TABLE 266 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 218
TABLE 267 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 218
TABLE 268 CHINA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 219
TABLE 269 CHINA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 219
TABLE 270 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 219
TABLE 271 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 220
TABLE 272 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 220
TABLE 273 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 220
TABLE 274 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 220
TABLE 275 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 221
TABLE 276 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 221
TABLE 277 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 221
10.4.2 JAPAN 222
10.4.2.1 Japan is the second-largest healthcare market in the world 222
TABLE 278 JAPAN: KEY INDICATORS 222
10.4.2.2 Impact of COVID-19 on the market in Japan 223
TABLE 279 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 223
TABLE 280 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 223
TABLE 281 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 224
TABLE 282 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 224
TABLE 283 JAPAN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 224
TABLE 284 JAPAN: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 225
TABLE 285 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 225
TABLE 286 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 225
TABLE 287 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 226
TABLE 288 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 226
TABLE 289 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 226
TABLE 290 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 226
TABLE 291 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 227
TABLE 292 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 227
10.4.3 INDIA 227
10.4.3.1 High blood donation and collection volumes indicate a strong growth potential 227
TABLE 293 INDIA: KEY INDICATORS 228
TABLE 294 INDIA: KEY INDICATORS 228
10.4.3.2 Impact of COVID-19 on the market in India 229
TABLE 295 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 229
TABLE 296 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 229
TABLE 297 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 230
TABLE 298 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 230
TABLE 299 INDIA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 230
TABLE 300 INDIA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 231
TABLE 301 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 231
TABLE 302 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 231
TABLE 303 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 232
TABLE 304 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 232
TABLE 305 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 232
TABLE 306 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 232
TABLE 307 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 233
TABLE 308 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 233
10.4.4 REST OF ASIA PACIFIC 233
TABLE 309 SURGICAL PROCEDURES IN SOUTH KOREA, 2019 234
TABLE 310 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 235
TABLE 311 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 235
TABLE 312 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 235
TABLE 313 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 236
TABLE 314 ROAPAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 236
TABLE 315 ROAPAC: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 236
TABLE 316 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 237
TABLE 317 ROAPAC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 237
TABLE 318 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 237
TABLE 319 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 238
TABLE 320 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 238
TABLE 321 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 238
TABLE 322 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 239
TABLE 323 ROAPAC: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 239
10.5 LATIN AMERICA 240
10.5.1 REDUCTIONS IN BLOOD DONATION RATE TO AFFECT MARKET GROWTH IN LATIN AMERICA 240
TABLE 324 LATAM: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 240
TABLE 325 LATAM: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 240
TABLE 326 LATAM: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 241
TABLE 327 LATAM: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 241
TABLE 328 LATAM: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 241
TABLE 329 LATAM: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 242
TABLE 330 LATAM: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 242
TABLE 331 LATAM: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 242
TABLE 332 LATAM: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 243
TABLE 333 LATAM: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 243
TABLE 334 LATAM: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 243
TABLE 335 LATAM: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 243
TABLE 336 LATAM: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 244
TABLE 337 LATAM: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 244
10.6 MIDDLE EAST & AFRICA 244
10.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES AND GROWING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 244
TABLE 338 MEA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 245
TABLE 339 MEA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 246
TABLE 340 MEA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2017–2020 (USD MILLION) 246
TABLE 341 MEA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2021–2026 (USD MILLION) 246
TABLE 342 MEA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2017–2020 (USD MILLION) 247
TABLE 343 MEA: PLASMA/WHOLE-BLOOD COLLECTION TUBES MARKET, BY TYPE, 2021–2026 (USD MILLION) 247
TABLE 344 MEA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2017–2020 (USD MILLION) 247
TABLE 345 MEA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2021–2026 (USD MILLION) 248
TABLE 346 MEA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2017–2020 (USD MILLION) 248
TABLE 347 MEA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2021–2026 (USD MILLION) 248
TABLE 348 MEA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 248
TABLE 349 MEA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 249
TABLE 350 MEA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2017–2020 (USD MILLION) 249
TABLE 351 MEA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2021–2026 (USD MILLION) 249
11 COMPETITIVE LANDSCAPE 250
11.1 OVERVIEW 250
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 250
TABLE 352 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE BLOOD COLLECTION DEVICES MARKET 250
11.3 REVENUE SHARE ANALYSIS 252
FIGURE 35 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE BLOOD COLLECTION DEVICES MARKET 252
11.4 MARKET SHARE ANALYSIS 253
FIGURE 36 BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 253
TABLE 353 BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION 253
11.5 BLOOD BAGS MARKET SHARE ANALYSIS 254
FIGURE 37 BLOOD BAGS MARKET SHARE ANALYSIS, BY PLAYER, 2019 254
11.6 COMPETITIVE LEADERSHIP MAPPING 255
FIGURE 38 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 256
11.7 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS 257
FIGURE 39 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020) 258
11.8 COMPANY FOOTPRINT 259
TABLE 354 COMPANY FOOTPRINT 259
TABLE 355 COMPANY PRODUCT FOOTPRINT 260
TABLE 356 COMPANY REGIONAL FOOTPRINT 261
11.9 COMPETITIVE SCENARIO 263
TABLE 357 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018– DECEMBER 2021 263
TABLE 358 KEY DEALS, JANUARY 2018– DECEMBER 2021 264
TABLE 359 OTHER KEY DEVELOPMENTS, JANUARY 2018–DECEMBER 2021 267
12 COMPANY PROFILES 268
12.1 KEY PLAYERS 268
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BECTON, DICKINSON AND COMPANY 268
TABLE 360 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 268
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 269
12.1.2 TERUMO BCT 275
TABLE 361 TERUMO BCT: BUSINESS OVERVIEW 275
FIGURE 41 TERUMO BCT: COMPANY SNAPSHOT (2020) 276
12.1.3 FRESENIUS KABI AG 280
TABLE 362 FRESENIUS KABI AG: BUSINESS OVERVIEW 280
FIGURE 42 FRESENIUS KABI AG: COMPANY SNAPSHOT (2020) 281
12.1.4 GRIFOLS, S.A. 284
TABLE 363 GRIFOLS, S.A.: BUSINESS OVERVIEW 284
FIGURE 43 GRIFOLS, S.A.: COMPANY SNAPSHOT (2020) 285
12.1.5 NIPRO MEDICAL CORPORATION 287
TABLE 364 NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW 287
FIGURE 44 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2020) 288
12.1.6 GREINER HOLDING AG 290
TABLE 365 GREINER HOLDING AG: BUSINESS OVERVIEW 290
FIGURE 45 GREINER HOLDING AG: COMPANY SNAPSHOT (2020) 291
12.1.7 QUEST DIAGNOSTICS INCORPORATED 294
TABLE 366 QUEST DIAGNOSTICS INCORPORATED: BUSINESS OVERVIEW 294
FIGURE 46 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2020) 294
12.1.8 SARSTEDT AG & CO. KG 297
TABLE 367 SARSTEDT AG & CO. KG: BUSINESS OVERVIEW 297
12.1.9 MACOPHARMA 300
TABLE 368 MACOPHARMA: BUSINESS OVERVIEW 300
12.1.10 HAEMONETICS CORPORATION 302
TABLE 369 HAEMONETICS CORPORATION: BUSINESS OVERVIEW 302
FIGURE 47 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2020) 303
12.1.11 SMITHS MEDICAL 305
TABLE 370 SMITHS MEDICAL: BUSINESS OVERVIEW 305
FIGURE 48 SMITHS MEDICAL: COMPANY SNAPSHOT (2020) 306
12.1.12 CARDINAL HEALTH 308
TABLE 371 CARDINAL HEALTH: BUSINESS OVERVIEW 308
FIGURE 49 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 309
12.1.13 RETRACTABLE TECHNOLOGIES, INC. 311
TABLE 372 RETRACTABLE TECHNOLOGIES, INC.: BUSINESS OVERVIEW 311
FIGURE 50 RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 312
12.2 OTHER PLAYERS 313
12.2.1 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. 313
TABLE 373 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.: BUSINESS OVERVIEW 313
12.2.2 FL MEDICAL S.R.L. 315
TABLE 374 FL MEDICAL S.R.L: BUSINESS OVERVIEW 315
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2.3 AB MEDICAL CO., LTD. 317
12.2.4 APTACA SPA 318
12.2.5 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD. 319
12.2.6 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S 319
12.2.7 AJOSHA BIO TEKNIK PVT. LTD. 321
12.2.8 PREQ SYSTEMS 322
12.2.9 CML BIOTECH (P) LTD. 323
12.2.10 LMB TECHNOLOGIE GMBH 324
12.2.11 MITRA INDUSTRIES PRIVATE LIMITED 325
12.2.12 NEOMEDIC LIMITED 326
13 APPENDIX 327
13.1 DISCUSSION GUIDE 327
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 332
13.3 AVAILABLE CUSTOMIZATIONS 334
13.4 RELATED REPORTS 334
13.5 AUTHOR DETAILS 335"
US $
Euro €
GBP £
